• New blood test to determine if you have or | Urik Alert!

    by admin on 2021-11-24 11:14:28

    New research in FASEB magazine shows that exposure of white blood cells to UVA light in agar to induce DNA damage can predict whether a person has cancer or is at risk for cancer

    American Federation of Experimental Biology Societies

    A new research

  • Non-random separation of sister chromosomes by Escherichia coli MukBEF NASA

    by admin on 2021-11-24 11:14:21

    View all hidden authors and organizations

    Edited by Nancy E. Kleckner of Harvard University in Cambridge, Massachusetts, approved on July 1, 2021 (reviewed on October 22, 2020)

    The round chromosomes in rod-shaped bacteria exist in the cell in two different configuratio

  • Close-up Photographer of the Year: 22 eye-catching award-winning photos

    by admin on 2021-11-24 11:14:03

    The mouse in the tire wheel, winner, young close-up photographer of the year: a mouse peeking out of the abandoned... []

    Under the motto "Re-examine the world", more than 9,000 photographers from 56 countries/regions participated in this year's Close-up Photographer of the Year (CUPOTY) co

  • Cancer in Nanocolor: A new type of microscope slide

    by admin on 2021-11-24 11:13:55

    We have updated our privacy policy to more clearly explain how we use your personal data.

    We use cookies to provide you with a better experience. You can read our Cookie Policy here.

    Pathologists often use tissue samples and microscopes to help diagnose diseases such as cancer. But di

  • Defective experiments fail to prove that the Covid-19 vaccine contains dangerous substances | Fact check

    by admin on 2021-11-24 11:13:29

    "Dr. Carrie Madej: The first U.S. laboratory to examine the'vaccine' vials, and the terrible findings show that," the title of September 29, 2021 claimed that this video has been viewed more than 2.5 million times on the video sharing platform Rumble. The clip is a segment of the Stew Peters Show

  • CD40L inhibits the growth of THP-1 cells by inhibiting PI3K/Akt | OTT

    by admin on 2021-11-24 11:12:49

    Javascript is currently disabled in your browser. When javascript is disabled, some functions of this website will not work.

    Open access for scientific and medical research

    From submission to the first editing decision.

    From editor acceptance to publication.

    The above perc

  • miRNA-195-5p reverses NSCLC cisplatin-resistant PGPM

    by admin on 2021-11-24 11:12:42

    Javascript is currently disabled in your browser. When javascript is disabled, some functions of this website will not work.

    Open access for scientific and medical research

    From submission to the first editing decision.

    From editor acceptance to publication.

    The above perc

  • Sec13 regulates the expression of specific immune factors related to inflammation in the body scientific report

    by admin on 2021-11-24 11:12:21

    Thank you for visiting Nature. The browser version you are using has limited support for CSS. For the best experience, we recommend that you use a newer version of the browser (or turn off the compatibility mode in Internet Explorer). At the same time, to ensure continued support, we will display

  • Entrepreneur of the day: David West, co-founder and CEO of Proscia

    by admin on 2021-11-24 11:11:57

    Today’s entrepreneur is David West, the co-founder and CEO of Proscia, a company that uses artificial intelligence to help pathologists improve patient outcomes.

    Proscia's platform is called Concentriq, which allows diagnostic laboratories and life science companies to capture, view, mana

  • Visit Genomeweb on LinkedIn

    by admin on 2021-11-24 11:11:49

    New York-Castle Biosciences plans to acquire Cernostics for $80 million to accelerate the sales and marketing of a test to predict the progression from Barrett's esophagus to high-grade dysplasia or esophageal adenocarcinoma.

    In addition, the transaction is in line with Castle Bio’s